Related Experiment Video
Updated: Aug 6, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species
1Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. patersond@dom.pitt.edu
Abstract:
Isolates of Pseudomonas aeruginosa or Acinetobacter species that are resistant to all, or almost all, commercially available antibiotics are now prevalent worldwide. Typically, these strains are recovered from patients in intensive care units who have ventilator-associated pneumonia. "Panresistant" strains can be defined as strains that are resistant to all beta -lactam and quinolone antibiotics recommended as empirical therapy for ventilator-associated pneumonia. These strains are well adapted to the hospital environment--molecular epidemiological studies have frequently revealed that only 1 or 2 clones caused outbreaks in intensive care units. However, panresistant strains may also be selected by antibiotic use. Given the lack of antibiotic options to treat infection with panresistant strains, enhanced surveillance for these organisms is necessary at unit-specific, institutional, and national levels.
Insights
Panresistant Pseudomonas aeruginosa and Acinetobacter strains are prevalent worldwide, often causing ventilator-associated pneumonia in intensive care units. Enhanced surveillance is crucial due to limited antibiotic treatment options for these highly resistant bacteria.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Prevalence of multidrug-resistant organisms, specifically Pseudomonas aeruginosa and Acinetobacter species, is a growing global concern.
- These panresistant strains, resistant to nearly all antibiotics, are frequently isolated from intensive care unit (ICU) patients with ventilator-associated pneumonia (VAP).
- Panresistance is defined by resistance to all beta-lactam and quinolone antibiotics recommended for empirical VAP treatment.
Purpose of the Study:
- To highlight the increasing prevalence and clinical significance of panresistant Pseudomonas aeruginosa and Acinetobacter species.
- To emphasize the association of these strains with ventilator-associated pneumonia in intensive care units.
- To underscore the urgent need for enhanced surveillance strategies.
Main Methods:
- Review of molecular epidemiological data on panresistant strain outbreaks.
- Analysis of clinical recovery data from intensive care units.
- Definition and characterization of panresistance in relation to empirical VAP therapy.
Main Results:
- Panresistant Pseudomonas aeruginosa and Acinetobacter isolates are now globally prevalent.
- These strains are predominantly found in intensive care units, often associated with ventilator-associated pneumonia.
- Molecular epidemiology indicates successful adaptation and dissemination of specific clones within hospital environments.
- Antibiotic use is identified as a potential selection pressure for panresistant strains.
Conclusions:
- Panresistant strains pose a significant threat due to the lack of effective antibiotic treatment options.
- Enhanced, multi-level surveillance (unit-specific, institutional, national) is essential for controlling the spread of these organisms.
- Urgent strategies are needed to combat infections caused by panresistant bacteria in healthcare settings.
Related Concept Videos
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
